P&PAULSON & CO. INC.
Institutional investor · Portfolio as of Q3 2021
Top Holdings38 positions
BAUSCH HEALTH COS INC | 25.8M | $719.6M | 20.5% | $21.16 | +31.61% | 9 qtrssince 2019-Q3 | Unchanged 0 |
HORIZON THERAPEUTICS PUB L | 6.2M | $675.8M | 19.3% | — | — | 9 qtrssince 2019-Q3 | Decreased 0 |
Acadian Asset Management Inc | 20M | $522.6M | 14.9% | $9.52 | +171.31% | 9 qtrssince 2019-Q3 | Unchanged 0 |
NOVAGOLD RESOURCES INC | 22.2M | $152.9M | 4.4% | $6.24 | +10.29% | 9 qtrssince 2019-Q3 | Unchanged 0 |
PERPETUA RESOURCES CORP | 24.8M | $123.4M | 3.5% | $5.90 | -15.61% | 3 qtrssince 2021-Q1 | Increased 66 |
Occidental Petroleum Corp | 3.8M | $110.9M | 3.2% | $24.43 | +12.66% | 4 qtrssince 2020-Q4 | Decreased 0 |
DIDI GLOBAL INC | 12.7M | $99M | 2.8% | $13.33 | -41.63% | 2 qtrssince 2021-Q2 | Increased 60 |
| 6M | $95.5M | 2.7% | $4.23 | +37.51% | 9 qtrssince 2019-Q3 | Unchanged 0 | |
| 4.5M | $82.1M | 2.3% | — | — | — | — | |
THRYV HOLDINGS INC | 2.6M | $79.2M | 2.3% | $13.50 | +122.52% | 4 qtrssince 2020-Q4 | Decreased 0 |
Cloudera Inc | 4.6M | $73.3M | 2.1% | — | — | 1 qtr | New 78 |
Pacira Biosciences | 1.3M | $70.5M | 2.0% | $40.51 | +38.25% | 9 qtrssince 2019-Q3 | Decreased 0 |
EXXON MOBIL CORP | 1.1M | $66.2M | 1.9% | $43.02 | +14.76% | 4 qtrssince 2020-Q4 | Decreased 0 |
Apa Corporation Com | 3M | $64.3M | 1.8% | $18.56 | -0.78% | 2 qtrssince 2021-Q2 | Decreased 0 |
ENDO INTERNATIONAL PLC | 17.3M | $56.1M | 1.6% | — | — | 9 qtrssince 2019-Q3 | Decreased 0 |
KIRKLAND LAKE GOLD LTD | 1.3M | $54.2M | 1.5% | — | — | 7 qtrssince 2020-Q1 | Decreased 0 |
BALLYS CORPORATION | 1M | $50.1M | 1.4% | — | — | 2 qtrssince 2021-Q2 | Unchanged 0 |
INTERNATIONAL TOWER HILL MIN | 61.9M | $46M | 1.3% | $0.55 | +36.22% | 9 qtrssince 2019-Q3 | Unchanged 0 |
ROYAL DUTCH SHELL-SPON ADR-A | 1M | $44.6M | 1.3% | $33.19 | +11.60% | 2 qtrssince 2021-Q2 | Decreased 0 |
TIM S A | 3.9M | $41.9M | 1.2% | $9.05 | -9.59% | 4 qtrssince 2020-Q4 | Unchanged 0 |
PAULSON & CO. INC. manages $3.5B across 38 positions as of Q3 2021. Top holdings: BHC (20.5%), HZNP (19.3%), AAMI (14.9%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.
Added 2 new positions, exited 4, increased 2, trimmed 15. Top move: CLDR (NEW, conviction 78). Portfolio: $3.5B across 38 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR